Latest News & Updates on Raydiant Oximetry Technology
Stay up-to-date with the latest press releases and company news. Explore insights, announcements, and milestones as we share our journey and keep you connected to what’s happening at Raydiant Oximetry.
Raydiant Oximetry Wins First Place in NIH RADx® Tech Fetal Monitoring Challenge Securing $750,000 in Prize Money
This challenge, co-sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the Bill & Melinda Gates Foundation, aims to accelerate the development of advanced fetal monitoring technologies to improve fetal and neonatal outcomes.
Raydiant Oximetry Secures $1 Million Grant to Advance Fetal Monitoring Technology
Raydiant Oximetry, Inc., a clinical-stage medical device company developing innovations to keep mothers and babies safe during childbirth, has announced the receipt of a $1 million grant from the Bill & Melinda Gates Foundation.
Raydiant Oximetry Kicks Off Series B Financing Round with an Investment from March of Dimes
Raydiant Oximetry, Inc., announced that it has received an investment from the March of Dimes Innovation Fund to kick off its Series B financing round.
AngelMD Portfolio Company Raydiant Oximetry Awarded FDA Breakthrough Device Status
The accelerated path to approval through the breakthrough device program will enable better care to millions of mothers and babies during childbirth.
Fogarty Innovation Graduate Raydiant Oximetry Raises $5 Million in Oversubscribed Series A2 Financing Round to Support Clinical Study
The funding was led by Avestria Ventures, which invests in early-stage women’s health companies, and syndicated by KOFA Healthcare, V-Capital, Band of Angels, FemHealth Ventures, RHIA Ventures, SteelSky Ventures and Tri-Valley Ventures.
Raydiant Oximetry Receives $3 Million Grant to Advance Its Innovative Technology
Raydiant Oximetry, a Fogarty Innovation graduate, is developing an innovative fetal monitor to improve outcomes for mothers and babies during childbirth and recently received a grant from the government of Ireland for approximately $3 million.
Raydiant Oximetry Wins First Place in NIH RADx® Tech Fetal Monitoring Challenge Securing $750,000 in Prize Money
This challenge, co-sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the Bill & Melinda Gates Foundation, aims to accelerate the development of advanced fetal monitoring technologies to improve fetal and neonatal outcomes.
Raydiant Oximetry Secures $1 Million Grant to Advance Fetal Monitoring Technology
Raydiant Oximetry, Inc., a clinical-stage medical device company developing innovations to keep mothers and babies safe during childbirth, has announced the receipt of a $1 million grant from the Bill & Melinda Gates Foundation.
Raydiant Oximetry Kicks Off Series B Financing Round with an Investment from March of Dimes
Raydiant Oximetry, Inc., announced that it has received an investment from the March of Dimes Innovation Fund to kick off its Series B financing round.
AngelMD Portfolio Company Raydiant Oximetry Awarded FDA Breakthrough Device Status
The accelerated path to approval through the breakthrough device program will enable better care to millions of mothers and babies during childbirth.
Fogarty Innovation Graduate Raydiant Oximetry Raises $5 Million in Oversubscribed Series A2 Financing Round to Support Clinical Study
The funding was led by Avestria Ventures, which invests in early-stage women’s health companies, and syndicated by KOFA Healthcare, V-Capital, Band of Angels, FemHealth Ventures, RHIA Ventures, SteelSky Ventures and Tri-Valley Ventures.
Raydiant Oximetry Receives $3 Million Grant to Advance Its Innovative Technology
Raydiant Oximetry, a Fogarty Innovation graduate, is developing an innovative fetal monitor to improve outcomes for mothers and babies during childbirth and recently received a grant from the government of Ireland for approximately $3 million.